laboratory infrastructure / processes using chemical / chemical synthesis / biotechnologies industrial bioproducts medical devices pharmaceuticals / natural health products / chemical and biochemical products / fermentation technologies / energy / /
MedicalCondition
Gram-negative sepsis / /
MedicalTreatment
antibiotics / /
Organization
FDA / European Union / /
Person
Alberta Innovates / / /
Position
Rod Szarka Business Development Manager / Manager Health / /
ProgrammingLanguage
L / /
Technology
UDP / fermentation technologies / drug development / MRI / /
UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc LpxC substrates used for new antibiotic development